By The formation of amyloid plaques in the brain is a hallmark of Alzheimer’s disease. But drugs designed to reduce accumulations of these plaques have so far yielded, at best, mixed results in clinical trials.
Swelling along brain’s axons may be true culprit in Alzheimer’s disease
Close Up Scientist using microscope in laboratory room while making medical testing and research
Comments